Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Mr. Manas Mengar as the Additional Independent, Non-Executive Director of the Company for the period of 5 (Five) Years subject to the approval of members in the General Meeting Aspira Pathlab & Diagnostics Ltd - 540788 - Outcome Of Board Meeting For Approval Of Financial Results & Limited Review Report For The Quarter Ended June 30,2023
Approval of the Financial Results and Limited Review Report for the quarter ended June 30, 2023 Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for For Notice Of Board Meeting To Consider Unaudited Financial Results Of The Company For The First Quarter
Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the Quarter ended 30th June, 2023 and to consider any other business with the permission of the Chair. Aspira Pathlab & Diagnostics Ltd - 540788 - Approval For Reclassification Of Mr. Bharat Tokarshi Dagha Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
BSE Limited vide their email dated July 11, 2023 has approved the application for reclassification of Mr.Bharat Tokarshi Dagha from the category of "Promoter " to "Public Shareholder". Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants)Regulations, 2018 for the quarter ended June 30, 2023. Aspira Pathlab & Diagnostics Ltd - 540788 - Closure of Trading Window
Intimation for Closure of Trading Window Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Resignation of Ms. Priya Pandey (Membership No. A66213), Company Secretary and Compliance Officer Aspira Pathlab & Diagnostics Ltd - 540788 - Intimation To Shareholders Holding Shares In Physical Mode Regarding Mandatory Furnishing Of PAN, KYC, Nomination And Bank Details As Per SEBI Circular Dated 16Th March, 2023
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith a copy of the letter along with necessary forms dispatched to the shareholders holding shares in physical mode, in compliance with the SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD-1/P/CIR/2023/37 dated 16th March, 2023. The physical shareholders are requested to furnish their PAN, KYC and Nomination details for updation to the Registrar and Transfer Agent of the Company (RTA) i.e. M/s. Link Intime India Private Limited. Further, the prescribed forms as per the aforesaid SEBI Circulars are available on the website of the Company www.aspiradiagnostics.com and the website of the RTA https://www.linkintime.co.in/. This is for your information and records. Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Annual Secretarial Compliance Report for the financial year ended March 31, 2023 issued by M/s. Nilesh A. Pradhan & Co., LLP, Practising Company Secretaries. Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication